Minnesota Oncology Hematology PA-Maplewood — Maplewood, Minnesota

Minnesota Oncology Hematology PA-Maplewood is a clinical research site located in Maplewood, Minnesota, United States 55109.

Crixeo Clinical Trials Trust Score: 34/100 (FAILING). This profile has not yet been claimed by the site owner.

Minnesota Oncology Hematology PA-Maplewood has participated in 456 clinical trials with 196 currently active.

Therapeutic areas: Adenocarcinoma of the Rectum, Stage II Rectal Cancer, Stage III Rectal Cancer.

Sponsors: ECOG-ACRIN Cancer Research Group, Alliance for Clinical Trials in Oncology, NSABP Foundation Inc.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Maplewood

Browse all research sites in Minnesota · View every site in Maplewood

Sponsor Feasibility Report

Trust Score: 34/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Minnesota Oncology Hematology PA-Maplewood?

Minnesota Oncology Hematology PA-Maplewood has a Crixeo Trust Score of 34/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Minnesota Oncology Hematology PA-Maplewood conducted?

Minnesota Oncology Hematology PA-Maplewood has 456 clinical trials on record, with 196 currently active. Their work covers Adenocarcinoma of the Rectum, Stage II Rectal Cancer, Stage III Rectal Cancer.

Is Minnesota Oncology Hematology PA-Maplewood accredited by Crixeo Clinical Trials?

Minnesota Oncology Hematology PA-Maplewood has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Minnesota Oncology Hematology PA-Maplewood?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.